B O O K - American College of Rheumatology

ACR/ARHP Poster Session B
1199. Type I IFN Signature in Pregnant Patients with Lupus. Danieli
Andrade 3 , Gloria C. Koo 3 , Patricia Redecha 3 , Kyriakos A. Kirou 3 ,
Mimi Kim 1 , Mary K. Crow 3 and Jane E. Salmon 2 , 1 Albert Einstein
College of Medicine, New York, NY, 2 Hospital for Special Surgery,
New York, NY, 3 Hospital for Special Surgery, New York, NY.
1200. Vitamin D and Vascular Stiffness in Patients with Systemic
Lupus Erythematosus. John A. Reynolds 3 , Sahena Haque 4 ,
Jacqueline L. Berry 4 , Lee-Suan Teh 2 , Pauline Ho 1 , Rachel
Gorodkin 1 and Ian N. Bruce 4 , 1 Central Manchester University
Hospitals NHS Foundation Trust, 2 East Lancashire Hospitals NHS
Trust, 3 University of Manchester, Manchester, United Kingdom,
4
University of Manchester.
Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s - Clinical
Aspects and Therapeutics II
1201. A Pilot Study To Evaluate Digital Perfusion in Scleroderma
Patients Treated with Oral Treprostinil. Ami A. Shah 2 , Laura
K. Hummers 2 , Kristan D. Rollins 4 , Susan Walker 4 , Mike Wade 4 ,
Cynthia Anderson 3 , Robert Wise 3 , Francesco Boin 2 and Fredrick
M. Wigley 1 , 1 Johns Hopkins University, Baltimore, MD, 2 Johns
Hopkins University, Baltimore, MD, 3 Johns Hopkins University,
4
United Therapeutics.
1202. An Analysis of Agreement of Guidelines for Management
in SSc from a Large Database (CSRG: Canadian Scleroderma
Research Group). Janet E. Pope 3 , Sarah Harding 4 , Sarit Khimdas 4 ,
Ash Bonner 2 , Murray Baron 1 and The CSRG, 1 Jewish General
Hospital, Montreal, QC, Canada, 2 McMaster University, 3 St
Joseph Health Care London, London, ON, Canada, 4 University of
Western Ontario.
1203. Are SSc Experts Doing What They Should Do? An Analysis of
Practice Variability in Large SSc Centers within the Canadian
Scleroderma Research Group (CSRG) Shows Practice
Differences. Sarah Harding 4 , Sarit Khimdas 4 , A. Bonner 2 , Murray
Baron 1 and Janet E. Pope 3 , 1 Jewish General Hospital, Montreal,
QC, Canada, 2 McMaster University, 3 St Joseph Health Care
London, London, ON, Canada, 4 University of Western Ontario.
1204. Assessing Health Status in Patients with Systemic Sclerosis:
Construct Validity of the Karnofsky Performance Status Score.
Christelle Nguyen 2 , Alice Bérezné 2 , François Rannou 3 , Caroline
Mestre-Stanislas 2 , Sandrine Morell-Dubois 1 , Loïc Guillevin 2 ,
Serge Poiraudeau 3 and Luc Mouthon 2 , 1 Universite Lille 2 ; Service
de Medecine Interne; Centre de Reference Pour la Sclerodermie
Systemique; Hopital Claude Huriez; Lille; France, 2 Universite
Paris Descartes; Faculte de Medecine Paris Descartes; Pole de
Medecine Interne, Centre de Reference Pour les Vascularites
Necrosantes et la Sclerodermie Systemique; Hopital Cochin;
Assistance Publique-Hopitaux de Paris (AP-HP); 3 Universite
Paris Descartes; Faculte de Medecine Paris Descartes; Service
de Medecine Physique et Readaptation; Hopital Cochin; AP-HP;
Inserm, Institut Federatif de Recherche sur le Handicap, Paris.
1205. Association of Gastrointestinal Involvement and Depressive
Symptoms in Patients with Systemic Sclerosis. Vijay Bodukam 1 ,
Ron D. Hays 2 , Paul Maranian 2 , Daniel E. Furst 2 , James R.
Seibold 3 , Ann Impens 4 , Maureen D. Mayes 5 , Philip J. Clements 2
and Dinesh Khanna 2 , 1 Interfaith Medical Center, Brooklyn,
Los Angeles, CA, 2 UCLA, 3 Univ of Connecticut, 4 University of
MIchigan, 5 University of Texas Houston.
1206. Bone Mineral Density and Body Composition in Systemic
Sclerosis: A Case-Control Study. Chi Chiu Mok, Ling Yin Ho, Chi
Hung To and Kwok Man Ma, Tuen Mun Hospital.
1207. Clinical Significance of Defined ANCA Positivity in Systemic
Sclerosis. Emma C. Derrett-Smith 2 , Svetlana Nihtyanova 2 ,
Jennifer Parker 1 , Christopher Bunn 1 , Aine Burns 1 , Mark A.
Little 1 and Christopher P. Denton 3 , 1 Centre for Immunology,
Royal Free Campus, UCL Medical School, London, 2 Centre for
Rheumatology and Connective Tissue Diseases, Royal Free
Campus, UCL Medical School, London, 3 Royal Free Hospital,
London, United Kingdom.
1208. Cognitive Impairment in Systemic Sclerosis. Neslihan Yilmaz 2 ,
Aynur Mollahasanoglu 1 , Meryem Can 2 , Müge Koçak 1 , Nese
Tuncer 1 , Nevsun Inanç 2 and Sule Yavuz 2 , 1 Marmara University,
Faculty of Medicine, Neurology Department, Istanbul, Turkey,
2
Marmara University, Faculty of Medicine, Rheumatology
Department, Istanbul, Turkey.
1209. Coronary Artery Calcification in Systemic Sclerosis: There
Was No Difference between SSc and Healthy Control Groups.
Young-Eun Park 2 , Seong-Hu Park 2 , Seung-Hoon Baek 2 , Jun-
Hee Lee 2 , Joung-Wook Lee 2 , Geun-Tae Kim 2 , Yeon-Ju Jeong 3 ,
Su-Yeon Choi 4 , Wan-Hee Yoo 1 and Sung-Il Kim 2 , 1 Chonbuk
National University Medical School, Jeonju, Jeonbuk, South
Korea, 2 Department of Internal Medicine, School of Medicine,
Pusan National University, Busan, South Korea, 3 Department
of Radiology, School of Medicine, Pusan National University,
Busan, South Korea, 4 Seoul National University Hospital
Healthcare System Gangnam Center, Seoul, South Korea.
1210. CXCL4, a Novel Marker for Systemic Sclerosis That Clearly
Correlates with the Clinical Hallmarks and Pathological Events.
Timothy Ruben Radstake 3 , Lenny van Bon 2 , Jasper Broen 2 ,
Romy Beatriz-Christmann 1 , Alsya Affandi 1 , Madelon Vonk 2 ,
Mike York 1 , Cindy Collins 1 , Mark Wenink 2 , Roger Hesselstrand 7 ,
Dirk Wuttge 7 , Sandeep Agarwal 6 , John Reveille 6 , Joost Drenth 2 ,
Jaqueline de Graaf 2 , Martin Den Heijer 2 , Cees Kallenberg 5 , Marc
Bijl 4 , Wim van den Berg 2 , Joosten Leo 2 , Waander van Heerde 2 ,
Piet van Riel 2 and Robert Lafyatis 1 , 1 Boston Medical Center,
2
Radboud University Nijmegen Medical Center, 3 Radboud
University Nijmegen Medical Center / Boston Medical Center,
Nijmegen, The Netherlands, 4 University Hospital Groninge,
5
University Hospital Groningen, 6 University Hospital Houston,
TX, 7 University Hospital Lund, Sweden.
1211. Determinants of Work Disability in Patients with Systemic
Sclerosis: A Longitudinal Study of the GENISOS Cohort.
Roozbeh Sharif 2 , Maureen D. Mayes 8 , Perry M. Nicassio 1 ,
Emilio B. Gonzalez 6 , Hilda T. Draeger 5 , Terry A. McNearney 7 ,
Deepthi K. Nair 3 , John D. Reveille 4 , Frank C. Arnett 9 and Shervin
Assassi 2 , 1 Department of Psychiatry, University of California, Los
Angeles, CA, 2 Division of Rheumatology and Immunogenetics,
University of Texas Health Science Center at Houston, Houston,
TX, 3 Division of Rheumatology and Immunogenetics, University
of Texas Health Science Center at Houston, Houston, TX, 4 Univ
Texas Health Sci Ctr, Houston, TX, 5 University of Texas Health
Science Center at San Antonio, San Antonio, TX, 6 University of
Texas Medical Branch at Galveston, Galveston, TX, 7 University
of Texas Medical Branch at Galveston, TX, 8 University of Texas-
Houston, Houston, TX, 9 UT Medical School, Houston, TX.
1212. Developing a Disease Activity and Therapeutic Response Index
in Connective Tissue Disease Related Interstitial Lung Disease
(CTD-ILD): Rationale, Aims, Design and Results from Tier 0,
the Pre-Delphi Exercise. Lesley Ann Saketkoo 4 , Dörte Huscher 2 ,
Dinesh Khanna 12 , Paul F. Dellaripa 1 , Kevin Flaherty 15 , Eric L.
Matteson 5 , Chester V. Oddis 16 , Kristine Phillips 14 , David Pittrow 3 ,
Athol Wells 8 , Christopher P. Denton 9 , Oliver Distler 11 , Otylia M.
Kowal-Bielecka 6 , Vibeke Strand 10 , Kevin K. Brown 7 and James R.
2010 Program Book 223